Brief: Adial Pharmaceuticals Received Notice Of Delisting From Nasdaq

Azora Therapeutics

24/05/2023 22:54

May 24 (Reuters) - Adial Pharmaceuticals Inc  ADIL.O :
    * ADIAL PHARMACEUTICALS INC -  ON MAY 19, RECEIVED NOTICE OF
DELISTING OR FAILURE TO SATISFY A CONTINUED LISTING RULE OR
STANDARD FROM NASDAQ

Source text for Eikon:  ID: 
Further company coverage:  ADIL.O 

 ((Reuters.Briefs@thomsonreuters.com;))